Prolactin Inhibits or Stimulates the Inflammatory Response of Joint Tissues in a Cytokine-dependent Manner

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Jose Fernando García-Rodrigo - , Universidad Nacional Autónoma de México (Author)
  • Georgina Ortiz - , Universidad Nacional Autónoma de México, Universidad Anáhuac (Author)
  • Oscar Fernando Martínez-Díaz - , Universidad Nacional Autónoma de México (Author)
  • Janette Furuzawa-Carballeda - , Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (Author)
  • Xarubet Ruíz-Herrera - , Universidad Nacional Autónoma de México (Author)
  • Fernando Macias - , Universidad Nacional Autónoma de México (Author)
  • María G. Ledesma-Colunga - , Universidad Nacional Autónoma de México (Author)
  • Gonzalo Martínez de la Escalera - , Universidad Nacional Autónoma de México (Author)
  • Carmen Clapp - , Universidad Nacional Autónoma de México (Author)

Abstract

The close association between rheumatoid arthritis (RA), sex, reproductive state, and stress has long linked prolactin (PRL) to disease progression. PRL has both proinflammatory and anti-inflammatory outcomes in RA, but responsible mechanisms are not understood. Here, we show that PRL modifies in an opposite manner the proinflammatory actions of IL-1β and TNF-α in mouse synovial fibroblasts in culture. Both IL-1β and TNF-α upregulated the metabolic activity and the expression of proinflammatory factors (Il1b, Inos, and Il6) via the activation of the nuclear factor-κB (NF-κB) signaling pathway. However, IL-1β increased and TNF-α decreased the levels of the long PRL receptor isoform in association with dual actions of PRL on synovial fibroblast inflammatory response. PRL reduced the proinflammatory effect and activation of NF-κB by IL-1β but increased TNF-α-induced inflammation and NF-κB signaling. The double-faceted role of PRL against the 2 cytokines manifested also in vivo. IL-1β or TNF-α with or without PRL were injected into the knee joints of healthy mice, and joint inflammation was monitored after 24 hours. IL-1β and TNF-α increased the joint expression of proinflammatory factors and the infiltration of immune cells. PRL prevented the actions of IL-1β but was either inactive or further increased the proinflammatory effect of TNF-α. We conclude that PRL exerts opposite actions on joint inflammation in males and females that depend on specific proinflammatory cytokines, the level of the PRL receptor, and the activation of NF-κB signaling. Dual actions of PRL may help balance joint inflammation in RA and provide insights for development of new treatments.

Details

Original languageEnglish
Article number164
JournalEndocrinology (United States)
Volume164
Issue number12
Publication statusPublished - 1 Dec 2023
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 37864848
ORCID /0000-0002-2061-8663/work/150329806

Keywords

ASJC Scopus subject areas

Keywords

  • IL-1β, NF-κB, TNF-α, prolactin receptor, rheumatoid arthritis, synovial fibroblasts, Tumor Necrosis Factor-alpha/pharmacology, Cells, Cultured, Inflammation/metabolism, Male, Prolactin/pharmacology, Animals, Fibroblasts/metabolism, Female, Mice, NF-kappa B/metabolism, Synovial Membrane/metabolism, Cytokines/metabolism, Arthritis, Rheumatoid/metabolism